Gene Page: SLC1A2
Summary ?
GeneID | 6506 |
Symbol | SLC1A2 |
Synonyms | EAAT2|GLT-1|HBGT |
Description | solute carrier family 1 member 2 |
Reference | MIM:600300|HGNC:HGNC:10940|Ensembl:ENSG00000110436|HPRD:02625|Vega:OTTHUMG00000044391 |
Gene type | protein-coding |
Map location | 11p13 |
Pascal p-value | 0.729 |
Sherlock p-value | 0.502 |
Fetal beta | -1.608 |
eGene | Cerebellar Hemisphere Myers' cis & trans |
Support | NEUROTRANSMITTER METABOLISM G2Cdb.human_BAYES-COLLINS-HUMAN-PSD-FULL G2Cdb.human_BAYES-COLLINS-MOUSE-PSD-CONSENSUS G2Cdb.human_clathrin G2Cdb.human_Synaptosome G2Cdb.human_TAP-PSD-95-CORE G2Cdb.humanNRC G2Cdb.humanPSD G2Cdb.humanPSP CompositeSet Darnell FMRP targets Potential synaptic genes |
Gene in Data Sources
Gene set name | Method of gene set | Description | Info |
---|---|---|---|
CV:GWASdb | Genome-wide Association Studies | GWASdb records for schizophrenia | |
CV:PGCnp | Genome-wide Association Study | GWAS | |
PMID:cooccur | High-throughput literature-search | Systematic search in PubMed for genes co-occurring with SCZ keywords. A total of 3027 genes were included. | |
Association | A combined odds ratio method (Sun et al. 2008), association studies | 2 | Link to SZGene |
Expression | Meta-analysis of gene expression | P value: 1.818 | |
Literature | High-throughput literature-search | Co-occurance with Schizophrenia keywords: schizophrenia,schizophrenic,schizophrenics,schizophrenias | Click to show details |
GO_Annotation | Mapping neuro-related keywords to Gene Ontology annotations | Hits with neuro-related keywords: 3 |
Section I. Genetics and epigenetics annotation
eQTL annotation
SNP ID | Chromosome | Position | eGene | Gene Entrez ID | pvalue | qvalue | TSS distance | eQTL type |
---|---|---|---|---|---|---|---|---|
rs17014160 | chr1 | 206855799 | SLC1A2 | 6506 | 0.07 | trans | ||
rs12997903 | chr2 | 1952083 | SLC1A2 | 6506 | 0.04 | trans | ||
rs6733654 | chr2 | 1963270 | SLC1A2 | 6506 | 9.781E-4 | trans | ||
rs6737451 | chr2 | 189039508 | SLC1A2 | 6506 | 0.02 | trans | ||
rs1395163 | chr3 | 31028951 | SLC1A2 | 6506 | 0.01 | trans | ||
rs17029291 | chr3 | 32402138 | SLC1A2 | 6506 | 0.04 | trans | ||
rs6446109 | chr3 | 60076988 | SLC1A2 | 6506 | 0.12 | trans | ||
rs624496 | chr3 | 120506736 | SLC1A2 | 6506 | 0.06 | trans | ||
rs7630338 | chr3 | 173953886 | SLC1A2 | 6506 | 0.05 | trans | ||
rs16858348 | chr3 | 173958675 | SLC1A2 | 6506 | 0.02 | trans | ||
rs2193745 | chr3 | 173964139 | SLC1A2 | 6506 | 0.07 | trans | ||
rs17049650 | chr4 | 119097017 | SLC1A2 | 6506 | 0.17 | trans | ||
rs17049690 | chr4 | 119154023 | SLC1A2 | 6506 | 0.04 | trans | ||
snp_a-4197792 | 0 | SLC1A2 | 6506 | 0.17 | trans | |||
rs17030258 | chr4 | 154546102 | SLC1A2 | 6506 | 0.18 | trans | ||
rs16895745 | chr5 | 26523381 | SLC1A2 | 6506 | 0.07 | trans | ||
rs3733925 | chr5 | 150090343 | SLC1A2 | 6506 | 0.17 | trans | ||
rs4576244 | chr6 | 9525542 | SLC1A2 | 6506 | 0.17 | trans | ||
rs10968711 | chr9 | 28676294 | SLC1A2 | 6506 | 0.17 | trans | ||
rs11259374 | chr10 | 14917473 | SLC1A2 | 6506 | 0.12 | trans | ||
rs3912874 | chr10 | 66571456 | SLC1A2 | 6506 | 0.19 | trans | ||
rs909288 | chr10 | 124257417 | SLC1A2 | 6506 | 0.01 | trans | ||
rs7111397 | chr11 | 20133985 | SLC1A2 | 6506 | 0.19 | trans | ||
rs7294586 | chr12 | 100890454 | SLC1A2 | 6506 | 0.12 | trans | ||
rs10492317 | chr12 | 100899426 | SLC1A2 | 6506 | 0.02 | trans | ||
rs1954396 | chr14 | 43601835 | SLC1A2 | 6506 | 0.01 | trans | ||
rs2327968 | chr20 | 15813490 | SLC1A2 | 6506 | 0.13 | trans | ||
rs6098023 | chr20 | 53113740 | SLC1A2 | 6506 | 0.18 | trans |
Section II. Transcriptome annotation
General gene expression (GTEx)

Gene expression during devlopment (BrainCloud)
Footnote:
A total of 269 time points ploted, with n=38 fetal samples (x=1:38). Each triangle represents one time point.
Gene expression of temporal and spatial changes (BrainSpan)
Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes the lower 25% and upper 25% of the expression distribution.
Top co-expressed genes in brain regions
Top 10 positively co-expressed genes | ||
Gene | Pearson's Correlation | Spearman's Correlation |
TGFBR3 | 0.81 | 0.85 |
FGL2 | 0.67 | 0.70 |
TLR4 | 0.67 | 0.79 |
PRRX1 | 0.66 | 0.76 |
SLC7A11 | 0.64 | 0.82 |
SIX1 | 0.63 | 0.54 |
CFH | 0.63 | 0.63 |
GJA1 | 0.63 | 0.75 |
ITGBL1 | 0.63 | 0.56 |
ABCA9 | 0.62 | 0.69 |
Top 10 negatively co-expressed genes | ||
Gene | Pearson's Correlation | Spearman's Correlation |
STRA13 | -0.36 | -0.53 |
SNHG12 | -0.35 | -0.47 |
RP9 | -0.34 | -0.46 |
RP9P | -0.33 | -0.51 |
TCTEX1D2 | -0.33 | -0.45 |
FAM128A | -0.33 | -0.38 |
COMTD1 | -0.32 | -0.38 |
AC006273.1 | -0.32 | -0.31 |
LSM7 | -0.32 | -0.46 |
NR2C2AP | -0.32 | -0.43 |
Section III. Gene Ontology annotation
Molecular function | GO term | Evidence | Neuro keywords | PubMed ID |
---|---|---|---|---|
GO:0015501 | glutamate:sodium symporter activity | IEA | glutamate (GO term level: 11) | - |
GO:0015293 | symporter activity | IEA | - | |
GO:0017153 | sodium:dicarboxylate symporter activity | IEA | - | |
Biological process | GO term | Evidence | Neuro keywords | PubMed ID |
GO:0007268 | synaptic transmission | TAS | neuron, Synap, Neurotransmitter (GO term level: 6) | 7521911 |
GO:0015813 | L-glutamate transport | TAS | glutamate (GO term level: 9) | 7521911 |
GO:0006835 | dicarboxylic acid transport | IEA | - | |
GO:0006810 | transport | IEA | - | |
Cellular component | GO term | Evidence | Neuro keywords | PubMed ID |
GO:0005624 | membrane fraction | TAS | 7521911 | |
GO:0016020 | membrane | IEA | - | |
GO:0016021 | integral to membrane | IEA | - |
Section V. Pathway annotation
Pathway name | Pathway size | # SZGR 2.0 genes in pathway | Info |
---|---|---|---|
KEGG AMYOTROPHIC LATERAL SCLEROSIS ALS | 53 | 43 | All SZGR 2.0 genes in this pathway |
REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | 186 | 155 | All SZGR 2.0 genes in this pathway |
REACTOME NEURONAL SYSTEM | 279 | 221 | All SZGR 2.0 genes in this pathway |
REACTOME TRANSMEMBRANE TRANSPORT OF SMALL MOLECULES | 413 | 270 | All SZGR 2.0 genes in this pathway |
REACTOME SLC MEDIATED TRANSMEMBRANE TRANSPORT | 241 | 157 | All SZGR 2.0 genes in this pathway |
REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | 94 | 65 | All SZGR 2.0 genes in this pathway |
REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | 49 | 36 | All SZGR 2.0 genes in this pathway |
TURASHVILI BREAST CARCINOMA DUCTAL VS LOBULAR UP | 21 | 14 | All SZGR 2.0 genes in this pathway |
ZHOU INFLAMMATORY RESPONSE LIVE UP | 485 | 293 | All SZGR 2.0 genes in this pathway |
GAL LEUKEMIC STEM CELL UP | 133 | 78 | All SZGR 2.0 genes in this pathway |
VECCHI GASTRIC CANCER EARLY DN | 367 | 220 | All SZGR 2.0 genes in this pathway |
ZHOU INFLAMMATORY RESPONSE FIMA UP | 544 | 308 | All SZGR 2.0 genes in this pathway |
ZHOU INFLAMMATORY RESPONSE LPS UP | 431 | 237 | All SZGR 2.0 genes in this pathway |
GOZGIT ESR1 TARGETS DN | 781 | 465 | All SZGR 2.0 genes in this pathway |
KIM MYCN AMPLIFICATION TARGETS UP | 92 | 64 | All SZGR 2.0 genes in this pathway |
WEI MYCN TARGETS WITH E BOX | 795 | 478 | All SZGR 2.0 genes in this pathway |
BENPORATH SUZ12 TARGETS | 1038 | 678 | All SZGR 2.0 genes in this pathway |
BENPORATH EED TARGETS | 1062 | 725 | All SZGR 2.0 genes in this pathway |
BENPORATH ES WITH H3K27ME3 | 1118 | 744 | All SZGR 2.0 genes in this pathway |
BENPORATH PRC2 TARGETS | 652 | 441 | All SZGR 2.0 genes in this pathway |
STARK PREFRONTAL CORTEX 22Q11 DELETION UP | 195 | 138 | All SZGR 2.0 genes in this pathway |
SHEN SMARCA2 TARGETS DN | 357 | 212 | All SZGR 2.0 genes in this pathway |
LEE LIVER CANCER CIPROFIBRATE DN | 66 | 43 | All SZGR 2.0 genes in this pathway |
LEE LIVER CANCER MYC UP | 54 | 30 | All SZGR 2.0 genes in this pathway |
POMEROY MEDULLOBLASTOMA DESMOPLASIC VS CLASSIC UP | 62 | 38 | All SZGR 2.0 genes in this pathway |
LEE LIVER CANCER DENA DN | 74 | 45 | All SZGR 2.0 genes in this pathway |
HU GENOTOXIN ACTION DIRECT VS INDIRECT 4HR | 37 | 22 | All SZGR 2.0 genes in this pathway |
SANSOM APC TARGETS | 212 | 121 | All SZGR 2.0 genes in this pathway |
KONDO PROSTATE CANCER HCP WITH H3K27ME3 | 97 | 72 | All SZGR 2.0 genes in this pathway |
HUANG DASATINIB RESISTANCE DN | 69 | 44 | All SZGR 2.0 genes in this pathway |
MOOTHA MITOCHONDRIA | 447 | 277 | All SZGR 2.0 genes in this pathway |
ICHIBA GRAFT VERSUS HOST DISEASE 35D DN | 49 | 34 | All SZGR 2.0 genes in this pathway |
YOSHIMURA MAPK8 TARGETS UP | 1305 | 895 | All SZGR 2.0 genes in this pathway |
RUTELLA RESPONSE TO CSF2RB AND IL4 UP | 338 | 225 | All SZGR 2.0 genes in this pathway |
RUTELLA RESPONSE TO HGF UP | 418 | 282 | All SZGR 2.0 genes in this pathway |
RUTELLA RESPONSE TO HGF VS CSF2RB AND IL4 DN | 245 | 150 | All SZGR 2.0 genes in this pathway |
CHIANG LIVER CANCER SUBCLASS CTNNB1 UP | 176 | 110 | All SZGR 2.0 genes in this pathway |
KIM ALL DISORDERS OLIGODENDROCYTE NUMBER CORR DN | 36 | 19 | All SZGR 2.0 genes in this pathway |
BRUINS UVC RESPONSE EARLY LATE | 317 | 190 | All SZGR 2.0 genes in this pathway |
PEDERSEN METASTASIS BY ERBB2 ISOFORM 4 | 110 | 66 | All SZGR 2.0 genes in this pathway |
RATTENBACHER BOUND BY CELF1 | 467 | 251 | All SZGR 2.0 genes in this pathway |
ZWANG TRANSIENTLY UP BY 2ND EGF PULSE ONLY | 1725 | 838 | All SZGR 2.0 genes in this pathway |
Section VI. microRNA annotation
miRNA family | Target position | miRNA ID | miRNA seq | ||
---|---|---|---|---|---|
UTR start | UTR end | Match method | |||
miR-128 | 6738 | 6744 | 1A | hsa-miR-128a | UCACAGUGAACCGGUCUCUUUU |
hsa-miR-128b | UCACAGUGAACCGGUCUCUUUC | ||||
miR-140 | 7101 | 7107 | 1A | hsa-miR-140brain | AGUGGUUUUACCCUAUGGUAG |
miR-145 | 9582 | 9588 | m8 | hsa-miR-145 | GUCCAGUUUUCCCAGGAAUCCCUU |
miR-153 | 8054 | 8060 | m8 | hsa-miR-153 | UUGCAUAGUCACAAAAGUGA |
miR-17-5p/20/93.mr/106/519.d | 8058 | 8064 | m8 | hsa-miR-17-5p | CAAAGUGCUUACAGUGCAGGUAGU |
hsa-miR-20abrain | UAAAGUGCUUAUAGUGCAGGUAG | ||||
hsa-miR-106a | AAAAGUGCUUACAGUGCAGGUAGC | ||||
hsa-miR-106bSZ | UAAAGUGCUGACAGUGCAGAU | ||||
hsa-miR-20bSZ | CAAAGUGCUCAUAGUGCAGGUAG | ||||
hsa-miR-519d | CAAAGUGCCUCCCUUUAGAGUGU | ||||
miR-182 | 182 | 189 | 1A,m8 | hsa-miR-182 | UUUGGCAAUGGUAGAACUCACA |
hsa-miR-182 | UUUGGCAAUGGUAGAACUCACA | ||||
miR-19 | 6614 | 6620 | 1A | hsa-miR-19a | UGUGCAAAUCUAUGCAAAACUGA |
hsa-miR-19b | UGUGCAAAUCCAUGCAAAACUGA | ||||
miR-200bc/429 | 1806 | 1813 | 1A,m8 | hsa-miR-200b | UAAUACUGCCUGGUAAUGAUGAC |
hsa-miR-200c | UAAUACUGCCGGGUAAUGAUGG | ||||
hsa-miR-429 | UAAUACUGUCUGGUAAAACCGU | ||||
hsa-miR-200b | UAAUACUGCCUGGUAAUGAUGAC | ||||
hsa-miR-200c | UAAUACUGCCGGGUAAUGAUGG | ||||
hsa-miR-429 | UAAUACUGUCUGGUAAAACCGU | ||||
miR-203.1 | 9564 | 9571 | 1A,m8 | hsa-miR-203 | UGAAAUGUUUAGGACCACUAG |
miR-218 | 8735 | 8741 | m8 | hsa-miR-218brain | UUGUGCUUGAUCUAACCAUGU |
hsa-miR-218brain | UUGUGCUUGAUCUAACCAUGU | ||||
hsa-miR-218brain | UUGUGCUUGAUCUAACCAUGU | ||||
miR-24* | 2362 | 2368 | 1A | hsa-miR-189 | GUGCCUACUGAGCUGAUAUCAGU |
miR-27 | 9613 | 9619 | 1A | hsa-miR-27abrain | UUCACAGUGGCUAAGUUCCGC |
hsa-miR-27bbrain | UUCACAGUGGCUAAGUUCUGC | ||||
hsa-miR-27abrain | UUCACAGUGGCUAAGUUCCGC | ||||
hsa-miR-27bbrain | UUCACAGUGGCUAAGUUCUGC | ||||
miR-29 | 7323 | 7329 | m8 | hsa-miR-29aSZ | UAGCACCAUCUGAAAUCGGUU |
hsa-miR-29bSZ | UAGCACCAUUUGAAAUCAGUGUU | ||||
hsa-miR-29cSZ | UAGCACCAUUUGAAAUCGGU | ||||
miR-30-5p | 108 | 114 | m8 | hsa-miR-30a-5p | UGUAAACAUCCUCGACUGGAAG |
hsa-miR-30cbrain | UGUAAACAUCCUACACUCUCAGC | ||||
hsa-miR-30dSZ | UGUAAACAUCCCCGACUGGAAG | ||||
hsa-miR-30bSZ | UGUAAACAUCCUACACUCAGCU | ||||
hsa-miR-30e-5p | UGUAAACAUCCUUGACUGGA | ||||
miR-31 | 277 | 284 | 1A,m8 | hsa-miR-31 | AGGCAAGAUGCUGGCAUAGCUG |
hsa-miR-31 | AGGCAAGAUGCUGGCAUAGCUG | ||||
miR-338 | 244 | 250 | 1A | hsa-miR-338brain | UCCAGCAUCAGUGAUUUUGUUGA |
miR-381 | 6654 | 6660 | 1A | hsa-miR-381 | UAUACAAGGGCAAGCUCUCUGU |
hsa-miR-381 | UAUACAAGGGCAAGCUCUCUGU | ||||
miR-96 | 4388 | 4394 | m8 | hsa-miR-96brain | UUUGGCACUAGCACAUUUUUGC |
- SZ: miRNAs which differentially expressed in brain cortex of schizophrenia patients comparing with control samples using microarray. Click here to see the list of SZ related miRNAs.
- Brain: miRNAs which are expressed in brain based on miRNA microarray expression studies. Click here to see the list of brain related miRNAs.